评估抗生素处方的目标指标清单:ESGAP横断面调查
2017年ESGAP对欧洲及非欧洲成员国开展三条目横断面调查,梳理国家级抗生素处方指标及其目标与激励措施。仅有6/21(29%)国家设有同时具备明确目标与激励的国家指标,共识别21种不同指标,各国在指标选择、测量单位与目标上差异显著。
要点
- 仅29%(6/21)国家设有兼具明确目标与激励的国家级抗生素处方指标
- 仅土耳其和克罗地亚报告常规将抗生素处方与临床诊断关联的计算机化系统
- 国家指标在指标选择、测量单位和目标上存在广泛差异
核心结论
- 在欧洲,同时具备明确目标和激励措施的国家级抗生素处方指标并不常用,各国在所选指标、测量单位和目标上存在广泛差异。
研究设计与样本
- 2017年在ESGAP成员中开展横断面调查(三条目问卷),成员来自23个欧洲国家和16个非欧洲国家。
- 23个欧洲国家中20个(87%)参与,另有1个非欧洲国家参与。
主要发现
- 仅有2个国家(土耳其和克罗地亚)报告存在常规将抗生素处方与临床诊断关联的计算机化系统。
- 6/21(29%)国家设有同时具备明确目标和激励的国家指标:保加利亚、克罗地亚、法国、荷兰、挪威和葡萄牙。
- 共识别21种不同指标,其中16种涉及住院患者(9个质量指标和7个数量指标),8种涉及门诊患者(均为数量指标),部分指标在两类场景均使用。
- 使用的激励类型包括筹资机制、医院认证和公开报告;部分受访者报告其国家在地区层面使用此类指标(如西班牙安达卢西亚和英国英格兰)。
关键数值与推荐
- 国家指标同时具备明确目标和激励的国家为6/21(29%)。
- 欧洲ESGAP网络国家参与率为20/23(87%)。
- 共识别21种不同指标:住院16种(9个质量指标、7个数量指标),门诊8种(均为数量指标)。
临床怎么用
- 可参考已设国家指标国家的指标类型与激励方式(筹资、认证、公开报告),用于本国抗菌药物管理项目的指标设计。
- 关注将抗生素处方与临床诊断常规关联的计算机化系统建设,以支撑指标监测。
局限性
- 调查为2017年横断面问卷,仅覆盖ESGAP网络成员国家,非欧洲国家参与仅1个。
- 指标与激励信息来自受访者报告,可能存在地区层面使用情况未被国家层面反映。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A variety of indicators is commonly used to monitor antibiotic prescriptions as part of national antimicrobial stewardship (AMS) programmes. OBJECTIVES: To make an inventory of indicators that assess antibiotic prescriptions and are linked to specific targets and incentives, at a national level. METHODS: A cross-sectional survey (three-item questionnaire) was conducted in 2017 among all ESGAP (ESCMID Study Group for Antimicrobial stewardshiP) members, coming from 23 European countries and 16 non-European countries. RESULTS: Almost all (20/23, 87%) European countries belonging to the ESGAP network participated, as well as one non-European country. Computerized systems routinely linking antibiotic prescriptions to clinical diagnoses were reported for only two countries (Turkey and Croatia). Only 6/21 (29%) countries had national indicators with both clear targets and incentives (Bulgaria, Croatia, France, the Netherlands, Norway and Portugal). We identified a total of 21 different indicators used in these countries, 16 concerning inpatients (9 quality indicators and 7 quantity metrics) and 8 concerning outpatients (all quantity metrics); some indicators were used in both settings. Three types of incentives were used: financing mechanism, hospitals' accreditation and public reporting. Some respondents reported that such indicators with both clear targets and incentives were used at a regional level in their country (e.g. Andalusia in Spain and England in the UK). CONCLUSIONS: National indicators, with clear targets and incentives, are not commonly used in Europe and we observed wide variations between countries regarding the selected indicators, the units of measure and the chosen targets.
引用
- Howard P, Huttner B, Beovic B, et al. ESGAP inventory of target indicators assessing antibiotic prescriptions: a cross-sectional survey. J Antimicrob Chemother. 2017. PMID: 29091207. doi:10.1093/jac/dkx243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。